Literature DB >> 10519247

Cryptosporidium parvum: synchronized excystation in vitro and evaluation of sporozoite infectivity with a new lectin-based assay.

J Gut1, R G Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10519247

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN： 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  29 in total

1.  Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells.

Authors:  Amna Hashim; Grace Mulcahy; Billy Bourke; Marguerite Clyne
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Cryptosporidium parvum oocyst viability and behaviour of the residual body during the excystation process.

Authors:  Sirri Kar; Arwid Daugschies; Ayse Cakmak; Nadim Yilmazer; Katja Dittmar; Berit Bangoura
Journal:  Parasitol Res       Date:  2011-05-21       Impact factor: 2.289

3.  Identification of Cryptosporidium parvum active chemical series by Repurposing the open access malaria box.

Authors:  Kovi Bessoff; Thomas Spangenberg; Jenna E Foderaro; Rajiv S Jumani; Gary E Ward; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 4.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

5.  Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.

Authors:  Mattie C Pawlowic; Sumiti Vinayak; Adam Sateriale; Carrie F Brooks; Boris Striepen
Journal:  Curr Protoc Microbiol       Date:  2017-08-11

6.  Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.

Authors:  W B Strong; J Gut; R G Nelson
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

8.  Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro.

Authors:  Raffaella Mele; Maria Angeles Gomez Morales; Fabio Tosini; Edoardo Pozio
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Pulsed-UV light inactivation of Cryptosporidium parvum.

Authors:  Soo-Ung Lee; Migyo Joung; Dong-Jin Yang; Soon-Ho Park; Sun Huh; Woo-Yoon Park; Jae-Ran Yu
Journal:  Parasitol Res       Date:  2008-02-20       Impact factor: 2.289

10.  The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated Proteoglycans.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.